PFA Annual Secretarial Audit Report for year ended 31st March ,2026
Awaiting price reaction for this filing.
MPS Pharmaa Limited (BSE Scrip Code: 531686) has submitted its Annual Secretarial Compliance Report for FY 2025-26. The secretarial auditor from Kundan Agrawal & Associates found the company largely compliant with SEBI regulations, but flagged three key deviations: (1) Non-payment of Annual Listing Fees to BSE for five consecutive years (FY 2021-22 to FY 2025-26) due to fund paucity; (2) Trading restrictions under BSE's Graded Surveillance Measure (GSM) Stage 4; (3) A Rs. 2,360 penalty (including GST) for late submission of the FY 2024-25 Annual Report uploaded under the wrong tab on BSE portal. Additionally, the company accepted unsecured interest-free related party loans of Rs. 752.40 lakh. The auditor noted the shares remain suspended from BSE with only weekly trade-for-trade trading allowed on the first trading day of every week until outstanding fees are cleared.
The company continues to face operational and regulatory challenges with suspended listing and restricted trading. Shareholders face liquidity constraints due to limited weekly trading. The company's inability to pay listing fees since FY 2021-22 signals ongoing financial distress despite management's assurance of future payment.